Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000552205 | SCV000659160 | likely benign | RASopathy | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000588692 | SCV000699632 | likely benign | not specified | 2019-08-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001556214 | SCV001777750 | likely benign | not provided | 2021-05-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002420542 | SCV002725749 | likely benign | Cardiovascular phenotype | 2020-11-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |